MAHLY लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (10 Jun 2024 @ 22:38):
Our systems believe the stock currently is undervalued by 3.61% compare to its pairs and should correct upwards.

Stats
आज की मात्रा	107
औसत मात्रा	33
बाजार मूल्य	3.09B
EPS	$62.80 ( Q4 \| 2024-03-31 )
अगली कमाई की तारीख	( $0 ) 2024-07-31
Last Dividend	$0.185 ( 2021-09-28 )
Next Dividend	$0 ( N/A )
P/E	11.75 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

CAKFY 0.00%

MAHLY 0.00%

सहसंबंध (AI algo v.1.1b): Undervalued: 3.61% $15.77 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

MediPal Holdings सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

MediPal Holdings वित्तीय

Annual	2024
राजस्व:	$3 558.73B
सकल लाभ:	$233.01B (6.55 %)
EPS:	$195.84

FY	2024
राजस्व:	$3 558.73B
सकल लाभ:	$233.01B (6.55 %)
EPS:	$195.84

FY	2023
राजस्व:	$3 360.01B
सकल लाभ:	$212.12B (6.31 %)
EPS:	$184.82

FY	2022
राजस्व:	$3 290.92B
सकल लाभ:	$205.11B (6.23 %)
EPS:	$140.13

Financial Reports:

No articles found.

MediPal Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

MediPal Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.45 - low (47.74%) | Divividend Growth Potential Score: 1.119 - No dividend expected

Information

First Dividend	$0.191	2021-03-29
Last Dividend	$0.185	2021-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.376	--
Avg. Dividend % Per Year	0.00%	--
Score	1.85	--
Div. Sustainability Score	4.45
Div.Growth Potential Score	1.119
Div. Directional Score	2.78	--

Next Divdend (Est)
(2024-12-19)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.85

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
28 Sep 2021	$0.185	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2021	$0.191	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SRGHY	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
CZNL	Ex Dividend Knight	2023-09-18	Quarterly	0.00%
NSARO	Ex Dividend Junior	2023-07-07	Quarterly	0.00%
BHWB	Ex Dividend Knight	2023-07-27	Quarterly	0.00%
JARLF	Ex Dividend Knight	2023-08-17	Semi-Annually	0.00%
UEPEN	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
FCELB	Ex Dividend Junior	2023-07-31	Semi-Annually	0.00%
RAFI	Ex Dividend Junior	2023-09-28	Quarterly	0.00%
CLPHY	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
LZRFY	Ex Dividend Junior	2023-07-03	Bi-Monthly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0231	1.200	9.23	10.00	[0 - 0.3]
returnOnEquityTTM	0.0708	1.500	-0.325	-0.487	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.235	0.800	8.83	7.06	[1 - 3]
quickRatioTTM	1.047	0.800	8.55	6.84	[0.8 - 2.5]
cashRatioTTM	0.228	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6 442.12	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.0655	1.000	-2.24	-2.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.0145	1.000	-1.710	-1.710	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.978	0.800	0.146	0.117	[0.5 - 2]
Total Score				4.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.96	1.000	8.89	0	[1 - 100]
returnOnEquityTTM	0.0708	2.50	-0.209	-0.487	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0.0151	1.500	9.62	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0323	1.500	-3.12	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.119

MediPal Holdings Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.